Naringin Alleviates Knee Osteoarthritis by Targeting TNF-α and PTGS2: An Integrated Network Pharmacology, Molecular Simulation, and Experimental Validation Study.

Researchers investigated naringin, a natural compound found in citrus fruits like grapefruit and oranges, to see if it could help reduce inflammation in knee osteoarthritis. Knee osteoarthritis is a painful condition where cartilage in the knee joint gradually breaks down, causing stiffness, swelling, and difficulty moving. The study used computer modeling and laboratory tests on human cartilage cells to understand how naringin works. Scientists discovered that naringin targets two important inflammatory proteins called TNF-alpha and PTGS2, which play major roles in causing joint inflammation and pain. When cartilage cells were exposed to inflammatory conditions similar to osteoarthritis, naringin helped the cells survive better and significantly reduced the production of these harmful inflammatory proteins. The effects were dose-dependent, meaning higher amounts of naringin produced stronger anti-inflammatory results. While this research is promising and suggests naringin could potentially be developed as a natural treatment option for knee osteoarthritis, it's important to note these were laboratory studies, not human trials. For patients with knee osteoarthritis currently seeking relief, acupuncture remains a well-established complementary therapy that many studies have shown can reduce pain and improve function. Acupuncture may work through different mechanisms than naringin, potentially reducing inflammation and modulating pain signals in the nervous system. If you're considering acupuncture for knee osteoarthritis, consult with a licensed acupuncturist certified by the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM).

This study employed network pharmacology, molecular docking, molecular dynamics simulations, and in vitro validation to investigate naringin's anti-inflammatory mechanisms in knee osteoarthritis. Network analysis identified 59 KOA-related targets, with TNF, PTGS2, TP53, CASP3, and PPARG as core targets. Pathway enrichment revealed predominant involvement in TNF and IL-17 signaling cascades. Molecular modeling demonstrated strong binding affinity and stable interactions between naringin and TNF-α/PTGS2. In vitro experiments using IL-1β-stimulated C28/I2 human chondrocytes showed naringin dose-dependently improved cell viability and significantly suppressed TNF-α and PTGS2 expression at both mRNA and protein levels. While no specific effect sizes or sample sizes were reported for the cellular experiments, results provide mechanistic evidence for naringin's chondroprotective effects via modulation of inflammatory mediators. Clinical relevance: This foundational research supports naringin as a potential complementary anti-inflammatory agent for osteoarthritis management, though human clinical trials are needed before therapeutic recommendations can be established.